Security key
034569103
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)
CUSIP: 034569103
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 7,343,734
- Total 13F value
- $14,173,448
- Share change
- +35,812
- SEC-reported price per share
- $1.93
- Number of holders
- 13
- Value change
- +$69,135
- Number of buys
- 4
- Number of sells
- 3
- Shares outstanding
- 41,587,315
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
13
Top holders
10
ANEB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Anebulo Pharmaceuticals, Inc. SEC filings
Anebulo Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 034569103
Recent filing periods:
Ownership snapshot
Top reported holders of ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
22NW, LP
Disclosed value leader
22NW, LP
Comparable rows
12/14
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 13%
2 rows are not safely comparable across share classes.
Showing 1-6 of 14 holder rows.
Quick read
22NW, LP leads the comparable SEC ownership view at 13%.
12 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 22NW, LP's linked filing trail.
Comparable ownership
Top 5
22NW, LP
13%
LVW Advisors, LLC
1.5%
Nantahala Capital Management, LLC
1.2%
MORGAN STANLEY
0.96%
Ikarian Capital, LLC
0.38%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 22NW, LP |
13F
Company
|
13%
|
$14,649,972
5,366,290 shares
|
— | 30 Jun 2024 |
| LVW Advisors, LLC |
13F
Company
|
1.5%
|
$1,752,767
642,039 shares
|
— | 30 Jun 2024 |
| Nantahala Capital Management, LLC |
13F
Company
|
1.2%
|
$1,395,229
511,073 shares
|
— | 30 Jun 2024 |
| MORGAN STANLEY |
13F
Company
|
0.96%
|
$1,089,868
399,219 shares
|
— | 30 Jun 2024 |
| Ikarian Capital, LLC |
13F
Company
|
0.38%
|
$430,964
157,862 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.37%
|
$420,073
153,873 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
7,343,734
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q4 2025 Across Filers
Q4 2025 holders
16
Q3 2024 holders
13
Holder diff
-3
| Investor | Q4 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend